Enviradene

This classification denotes an antiviral agent with the molecular formula C19H21N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9Q79A81839, chemically known as 1h-benzimidazol-2-amine, 1-((1-methylethyl)sulfonyl)-6-(1-phenyl-1-propenyl)-, (e)- but generally known as enviradene, which bears US NIH Compound Identifier 6435398. European Medicines Agency schedules Enviradene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06555MIG. The term ENVIRADENE is an International Non-Proprietary Name. ENVIRADENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule enviradene under HS 29339990 and SITC 51577. As of Q4 2014, ENVIRADENE remains the US FDA Preferred Term for this commodity. Enviradene bears US NLM identifiers UMLS ID C0116243 and NCI Concept Code C65514. SMILES: S(=O)(=O)(N1C2C(NC1N)CCC(C2)/C(=C/C)C1CCCCC1)C(C)C.